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BioactivitiesAbstract (Z)-4-(4-cyanophenylamino)-4-oxobut-2-enoic acid (LH) and its new triphenyltin (IV)
derivative (Ph3SnL) were synthesized and further investigated for their binding with ds.DNA under
physiological conditions {pH: 4.7 (stomach); 7.4 (blood), 37 C} using UV–Visible/ﬂuorescence
spectroscopy, cyclic voltammetry and viscosity measurement techniques. Spectral responses as well
as experimental ﬁndings from all the techniques i.e., binding constant (Kb), binding site size (n) and
free energy change (DG) correlated with each other and indicated formation of spontaneous
compound–DNA complexes via intercalation of compounds into the DNA base pairs. Values of
kinetic parameter, Kb, revealed comparatively greater binding of both the compounds with DNA
at stomach pH (4.7). However among both compounds organotin complex (Ph3SnL) showed
comparatively greater binding than that of its ligand (LH) as evident from its, Kb, values at both
the pH values. In general, Kb values were evaluated greater for Ph3SnL at stomach pH {: Kb:
8.65 · 104 M1 (UV); 5.49 · 104 M1 (ﬂuorescence); 8.85 · 104 M1 (CV)}. Voltammetric responses
of both compounds before and after the addition of DNA indicated that diffusion controlled
processes are involved. Complex Ph3SnL exhibited the best antitumor activity.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
The increasing interest in organotin(IV) carboxylates in recent
years has, to a large extent, been prompted by their structural
diversity (Ali et al., 2007; Tiekink, 1991; Tiekink, 1994) and
broad therapeutic activity (Hadjikakou and Hahjiliadis,
2009; Nagy et al., 2008). Information on the structural aspects
452 N. Arshad et al.of organotin(IV) carboxylates is a continuous discussion and
at the same time some new applications of high importance
are being discovered which are relevant to their medicinal
applications (Gielen, 1996; Kaluderovic et al., 2010;
Sirajuddin et al., 2014). An immense curiosity in the chemistry
of organotin(IV) compounds has led to the extended studies on
their reactions with different biomolecules e.g., carbohydrates,
nucleic acid derivatives, amino acids and peptides (Yang and
Guo, 1999; Nath et al., 2001). In general triorganotin(IV) com-
pounds display a large array of biological activities than their
diorganotin and monoorganotin analogues. This has been
attributed to their ability to bind with proteins (Pettinari and
Marchetti, 2008). Furthermore, many organotin(IV) carboxyl-
ates have been found to possess anticancer activity in a variety
of tumor cells and the structures of these organotin(IV) com-
pounds have been characterized both in solid and solution
forms (Hadjikakou and Hahjiliadis, 2009; El-Sherif, 2012).
In recent years DNA bindings/cleavage with organotin(IV)
has become the main subject of study for many researchers
(Alama et al., 2009; Camm and McGowan, 2009; Tabassum
and Pettinari, 2006; Tabassum et al., 2012; Shujha et al.,
2010). Most of the published papers describe experimental
and theoretical studies of the interaction of organotin(IV)
compounds with DNA. Such organotin(IV)–DNA interac-
tions suggest possible antitumor activities of organotin(IV)
compounds. It is well known that DNA itself is an important
target of anti-tumor drugs with different types of interactions
which can often cause DNA damage in cancer cells, blocking
the division of cancer cells and ultimately results in death of
cancer cells (Tabassum and Pettinari, 2006). The binding abil-
ity of organotin(IV) compounds with DNA depends on the
coordination number and nature of the groups bonded to cen-
tral tin atom. Small molecules bind to DNA through covalent
or non-covalent interactions. Such binding can take place
either with the nitrogenous bases or negatively charged oxygen
of the phosphate backbone of DNA (Tabassum and Pettinari,
2006).
Keeping in view the great importance of organotin carbox-
ylates and in continuation of our previous work on DNA
binding studies with different molecules (Arshad et al., 2013;
Arshad et al., 2012a,b), present research has been focused on
synthesis, characterization and investigation on binding inter-
actions of (Z)-4-(4-cyanophenylamino)-4-oxobut-2-enoic acid
(LH) and its triphenyltin derivative (Ph3SnL) with DNA using
UV–Visible spectroscopy, ﬂuorescence spectroscopy, cyclic
voltammetry, and viscosity measurements. These compounds
were also investigated for their antioxidant and antitumor
potential by using different bioassays.2. Materials and methods
2.1. Chemicals and reagents
All reagents were procured from Aldrich/Fluka and used with-
out further puriﬁcation. All the solvents were dried before use
by the literature methods. The ligand (LH) and its triphenyl-
tin(IV) (Ph3SnL) complex were prepared as given in Schemes
1 and 2. DNA was extracted in the laboratory from chicken
blood by the Falconmethod (Sambrook et al., 1989) and its con-
centration was determined spectrophotometrically at 260 nm
using molar extinction coefﬁcient, e260 = 6600 cm
1 M1(Reichmann et al., 1954). Purity of DNA was checked by mon-
itoring the ratio of the absorbance at 260 nm to that at 280 nm
and solution gave a ratio of A260/A280 > 1.8, indicating that
DNA was sufﬁciently pure and free from protein (Babkina
and Ulakhovich, 2005). The stock solutions of LH and Ph3SnL
were prepared by dissolving them in buffer solution of pH 4.7
(acetate buffer; CH3COOH+ CH3COONa) and pH 7.4 (phos-
phate buffer; Na2HPO4 + NaH2PO4). Autoclaved water was
used to prepare all the solutions.
2.2. Methods
2.2.1. Synthesis
The ligand precursor (LH) was obtained from the reaction of
maleic anhydride with 4-aminobenzonitrile in ethyl acetate as
shown in Scheme 1. A solution of maleic anhydride (0.98 g,
10 mmol) in 50 mL ethyl acetate was added to a solution of
4-aminobenzonitrile (1.18 g, 10 mmol) in 50 mL ethyl acetate
in a 250 mL conical ﬂask. The mixture was stirred for three
hours at room temperature. After stirring the precipitates of
ligand acid were ﬁltered and recrystallized with ethanol.
The triphenyltin(IV) complex (Ph3SnL) was obtained from
the reaction of Ph3SnOH with ligand precursor in a 1:1 molar
ratio. In a typical procedure, equimolar amounts of ligand pre-
cursor (2.16 g, 10 mmol) and triphenyltin hydroxide (3.17 g
10.mmol) were suspended in 100 mL of dry ethanol/acetone
(8:2) solvent mixture and reﬂuxed for 8 h. After cooling to
room temperature, reaction mixture was ﬁltered and solvents
were evaporated in a rotary evaporator. The solid obtained
was recrystallized from chloroform with few drops of
n-hexane. The general chemical reaction is given in Scheme 2.
2.2.2. Physical data
LH: Yield 77%, m.p.: 190–192 C. FTIR data (KBr, cm1): m
(NH) 3291, m (OH) 3204, m (CN) 2229, masym (COO) 1713, msym
(COO) 1420, Dm= 297, m (NHCO) 1628.
1H NMR data (DMSO, ppm 3J(1H, 1H) in Hz): 12.92 (b,
1H, CONH), 10.73 (s, 1H, H-1), 7.92 (d, 2H, (8.0), H-6,60),
7.82 (d, 2H, (8.0), H-7,70), 6.57 (d, 1H, (12), H-2), 6.36 (d,
1H, (12), H-3).
13C NMR data (DMSO, ppm): 166.9 (C1), 130.3 (C2),
131.5 (C3), 163.9 (C4), 142.9 (C5), 119.4 (C6), 118.9 (C7),
133.3 (C8), 105.3 (C9).
Ph3SnL: Yield 70%, m.p.: 160–162 C. FTIR data (KBr,
cm1): m (NH) 3301, m (CN) 2228, masym (COO) 1671, msym
(COO) 1481, Dm= 190, m (NHCO) 1622, m (Sn–O) 454.
1H NMR data (CDCl3, ppm
3J(1H, 1H) in Hz): 11.63 (b,
1H, CONH), 7.81 (d, 2H, (8.4), H-6,60), 7.62 (d, 2H, (8.4),
H-7,70), 7.75–7.68 and 7.54–7.45 (m, 15H, SnPh), 6.38 (d,
1H, (13.2), H-2), 6.28 (d, 1H, (13.2), H-3).
13C NMR data (CDCl3, ppm,
nJ[119Sn, 13C] in Hz): 171.9
(C1), 129.2 (C2), 129.7 (C3), 162.4 (C4), 142.2 (C5), 119.8
(C6), 119.0 (C7), 128.8 (C8), 107.0 (C9), 137.7 [655] (Ca),
136.7 [46.8] (Cb), 130.7 [22.6] (Cc), 128.0 (Cd).
2.3. Instrumentations
The melting points were determined in capillary tubes using a
MPDMitamura Riken Kogyo (Japan) Electro thermal melting
point apparatus and were uncorrected. FTIR spectra (KBr)
were recorded on a Nicolet iS 10 FTIR spectrophotometer in
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Scheme 2 Synthesis of triphenyltin(IV) complex (Ph3SnL).
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were recorded on a Bruker Avance 400 spectrometer operating
at 400 MHz. The electronic absorption spectra were recorded
on a Shimadzu 1800 spectrophotometer (TCC-240A, Japan)
equipped with temperature control device using 1.0 cm
matched quartz cells. Fluorescent emission spectra were
recorded on an F-7000 FL spectrophotometer 2133-007. Cyclic
voltammetric experiments were performed using AUTOLAB
PGSTAT–302 with GPES version 4.9 (Eco Chemie, Utrecht,
Netherlands).
Electrochemical measurements were carried out in a dried
conventional three electrode cell using a glassy carbon
(GCE; d= 3 mm) working electrode, a saturated calomel
(SCE; 3.5 M KCl) reference electrode and a Pt sheet counter
electrode. Prior to each experiment the GCE was polished with
alumina powder and rinsed thoroughly with doubly distilled
water and ultrasonicated for 30 s.
2.4. UV–Visible and ﬂuorescence spectroscopy
Concentration of DNA as determined by a UV–Visible spec-
trophotometer at 260 nm was found 1.8 · 104 M. Spectro-
scopic titrations were carried out at stomach pH (4.7) andblood (7.4) and at 37 C (body temperature). The absorbance
measurements by UV–Visible spectrophotometer and the ﬂuo-
rescence emission spectra by ﬂuorescence spectrophotometer
were recorded by keeping the concentration of LH and
Ph3SnL constant (2.8 · 105 M) in the sample cell, while vary-
ing the concentration of ds.DNA from 10 to 60 lM in the sam-
ple cell. In order to achieve the equilibrium between the
compound and DNA, solutions were allowed to stay for at
least 5 min before each measurement was made. After placing
the sample solutions within the cell cavity and before running
the spectra, required temperature (37 C) was maintained on
temperature controlled device.
2.5. Cyclic voltammetry
First a blank CV was run with the buffer solutions (4.7 and
7.4) at 37 C, which showed no electroactivity in the potential
range of our interest (2 to +2 V). Cyclic voltammograms of
LH and Ph3SnL (2.8 · 105 M) were recorded from 2.0 to
+1.0 V vs. SCE before and after the addition of different vol-
umes (ll) of the stock DNA solution corresponding to the ﬁnal
concentration of DNA ranging from 10 to 60 lM within the
cell. Scan rate of 100 mV/s was used throughout the experi-
ments. All measurements were made at 37 C after purging
the solution in the cell with argon gas (99.999%) for at least
10–15 min to exclude oxygen before every electrochemical
assay.
2.6. Viscosity measurements
At ﬁrst viscosity of DNA solution (go) was determined at
stomach (4.7) and blood (7.4) pH under physiological temper-
ature (37 C). Then speciﬁc viscosity contribution (g), due to
DNA (10 lM) in the presence of increasing concentration of
investigated compound was determined. The values of the rel-
ative speciﬁc viscosities for the compounds i.e., (g/go)
1/3 were
then plotted against the ratio; [compound]/[DNA].
2.7. DPPH radical scavenging experiment
DPPH free radical scavenging activity of test compounds was
carried out by already reported methods (Arshad et al., 2013;
Arshad et al., 2012a; Nawaz et al., 2009). Compounds were
examined at four concentrations 7.4, 22.2, 66.6 and
200 lg ml1 as ﬁnal concentrations from stock. Reaction mix-
ture was prepared by adding 0.1 ml of each test compound
solution in DMSO, 2 ml of 0.1 mM DPPH in ethanol solution
and 0.9 ml of 50 mM Tris–HCl in capped vials. DMSO was
used as negative and ascorbic acid was used as positive control,
respectively. Reaction mixture was incubated in the dark for
30 min at room temperature. After incubation, change in
454 N. Arshad et al.DPPH color was observed by spectrophotometric absorbance
at 517 nm. Mixture of all solvents utilized in the assay was
used as blank for the spectrophotometer. Percent scavenging
of DPPH free radical for each concentration of each com-
pound was calculated.
2.8. Potato disc antitumor assay
Potato disc antitumor assay with some modiﬁcations was per-
formed to detect the tumor inhibition activity of compounds
under investigation (Arshad et al., 2013; Arshad et al.,
2012a; Ahmad et al., 2008). In this assay 48 hour old single col-
ony culture of Agrobacterium tumefaciens (At-10) strain was
used as tumor inducing agent on potato discs. Each test sample
was evaluated for antitumor activity at four concentrations
i.e., 7.4, 22.2, 66.6, and 200 lg ml1 with DMSO as negative
controls and vincristine as standard drug. Under complete
aseptic conditions, potato discs (0.5 cm thickness) were made
by using sterilized instruments from surface sterilized (HgCl2
0.1%) healthy potato tubers. Fifteen potato discs were trans-
ferred on each petriplate containing 1.5% agar–agar in dis-
tilled water. After treatment with test compounds and At-10
strain on each disc, these petriplates were then incubated at
28 C for 21 days. Number of tumors was counted after stain-
ing with the Lugol’s solution (10% KI and 5% I2) with the
help of a dissecting microscope. Percentage tumor inhibition
was calculated. Each experiment was carried out in triplicate
and IC50 values for each compound were calculated.3. Results and discussion
3.1. Ligand precursor and triphenyltin(IV) complex
The ligand precursor (LH) was obtained from the reaction of
maleic anhydride with 4-aminobenzonitrile in ethyl acetate as
shown in Scheme 1 while its triphenyltin(IV) complex (Ph3SnL)
was obtained from the reaction of Ph3SnOH with ligand pre-
cursor in a 1:1 molar ratio as given in Scheme 2. Both ligand
precursor and triphenyltin(IV) complex are stable in moist air
and soluble in common organic solvents like CHCl3, CH2Cl2
and DMSO.
The Infra red spectra of both compounds were recorded in
the range of 4000–400 cm1 and important bands are given
along with synthesis in experimental section. The tentative
assignments are made on the basis of reported literature values
and by comparing both compounds. The most signiﬁcant IR
bands are m(OH), m(COO) and m(Sn–O) in both compounds.
The explicit feature observed in the spectra of the synthesized
triphenyltin(IV) is the absence of the broad band 3204 cm1,
which appears in the free ligand precursor as the m(O–H) vibra-
tion, thus indicating Sn–OCO bond formation through this
site. The difference, [Dm= masym(COO)  msym(COO)], has
been used to predict the mode of tin carboxylate interaction
and may help to elucidate the structure and bonding mode.
The Dm value of 192 cm1 for the synthesized organotin reﬂects
the bidentate nature of the carboxylic group (Rehman et al.,
2012). Thus comparing with earlier report (Bhatti et al.,
2013) the tin atom approaches ﬁve coordination and carboxyl-
ate group acts as bridging bidentate ligand leading to trigonal
bipyramidal with trans-R3SnO2 geometry. The IR band
454 cm1 indicates the presence of Sn–O bond for the complex.1H and 13C NMR for both ligand precursor and organotin
complex were recorded in DMSO and CDCl3, respectively and
are given along with synthesis in experimental section. The
most down ﬁeld signal in ligand precursor is at 12.92 ppm
for the CONH group while acid proton (COOH) appears at
10.73 ppm. Aromatic protons and ethylene protons appear
as doublet in the expected range. The disappearance of signal
of acid proton in the spectrum of Ph3SnL further strengthens
the formation of complex. In addition, the phenyl group
attached with Sn atom gives complex multiplets in range of
7.45–7.75 ppm. In 13C NMR the carboxylate carbon resonates
organotin complex at 171.9 ppm while this carboxylate carbon
appears at 166.9 ppm in ligand precursor, reﬂecting the
participation of the COO group in coordination with tin.
Tin-phenyl carbons resonate in expected range with well
deﬁned tin-carbon nJ[119Sn–13C] couplings. In mass spectrum
of ligand precursor, molecular ion peak [M+] appears at 216
(10) while low intensity molecular ion peak [M+] is observed
at 566 (3) in case of organotin complex.3.2. DNA binding study by UV-spectroscopy
UV–Visible spectral changes before and after the addition of
various concentrations of compound into the ﬁxed concentra-
tion of DNA lead to predict interaction and binding mecha-
nism of compound with DNA (Ruiz et al., 2011).
In present studies, pure spectra of LH and Ph3SnL both
having same concentration (2.8 · 105 M) were recorded sepa-
rately, Fig. S1 (in supplementary information). All solutions
were prepared in ethanol-water mixture (7:3). A single peak
for LH and Ph3SnL compounds appears at kmax of 288.2 and
302 nm respectively. The molar extinction coefﬁcient (e) values
were evaluated as 16,025 cm1 M1 and 14,612 cm1 M1
respectively for LH and Ph3SnL and indicated that p-p
* transi-
tions are operative for both compounds in the kmax range of
240–390 nm, Figs. S2 and S3 (concentration proﬁle; in supple-
mentary information). Absorption spectrum of pure chicken
blood ds-DNA recorded in double deionized distilled water
showed a broad band at kmax of 260 nm. The observed maxi-
mum arises due to purine and pyrimidine moieties having chro-
mophoric centers. The absorbance ratio (A260/A280) assured
that DNA is pure as its value was found to be 1.83 (Babkina
and Ulakhovich, 2005).
After the addition of varying concentrations of DNA
(10–60 lM) on a ﬁxed concentration (2.8 · 105 M) of LH
and Ph3SnL, hypochromic effect (a gradual decrease in absor-
bance peak intensity) of extent 46.34% and 49.89% respec-
tively at pH 4.7 and 44.46% and 47.76% respectively at pH
7.4 along with gradual blue shift of magnitude 6.4 and
8.6 nm respectively at pH 4.7 and 2.0 and 4.0 nm respectively
at pH 7.4 was observed in the UV-spectra, Fig. 1. Percent
decrease in the absorption peak intensities of LH and Ph3SnL
in the presence of DNA was calculated, using Eq. (1).
H% ¼ Afree  Abound
Afree
 100 ð1Þ
Change in the spectral behavior of both the compounds after
the addition of DNA inferred their binding with the DNA
(Tabassum et al., 2012; Arshad et al., 2013; Arshad et al.,
2012a; Ruiz et al., 2011). Further, hypochromic effect after
the addition of DNA is evocative of compound–DNA complex
Figure 1 UV-spectra for (A) LH, (B) Ph3SnL, (2.8 · 105 M) without and in the presence of 10–60 lM DNA at pH 4.7 (left hand side)
and pH 7.4 (right hand side) and at 37 C. The arrow direction indicates increasing concentrations of DNA.
Figure 2 Plots of Ao/A  Ao vs. 1/[DNA] for the application of
Benesi-Hildebrand equation for calculation of (A) LH–DNA, (B)
Ph3SnL–DNA binding constant at pH 4.7 and 7.4 and at 37 C.
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the DNA base pairs generally arises due to the overlapping of
p*-orbital of intercalated ligand with p-orbital of the base
pairs. Transition probabilities decrease due to partially ﬁlled
coupling p-orbital of DNA and as a consequence hypochro-
mism is observed in the spectra (Xu et al., 2008).
Furthermore, spectra of Ph3SnL–DNA complex were fol-
lowed by an isosbestic point at both the pH values, Fig. 1,
which is indicative of an equilibrium between bound DNA
and the free form of the compounds and that no species other
than the free and the intercalated complexes is present in the
reaction mixture (Kohn et al., 1975).
Variation in the absorbance spectrum of a compound after
the addition of DNA leads to determine the binding kinetics
i.e., binding/formation constant ‘‘Kb’’ of compound–DNA
complex with the help of Benesi-Hildebrand equation (Kuntz
et al., 1968). Using UV-absorption data in Hildebrand equa-
tion, Kb values for LH and Ph3SnL for their binding with
DNA were evaluated at both stomach (4.7) and blood (7.4)
pH and at temperature 37 C.
Ao
A Ao ¼
eG
eHG  eG þ
eG
eHG  eG
1
Kb½DNA ð2Þ
where Ao and A are the absorbance, while EG and EHG are the
molar extinction coefﬁcient of compound and complex respec-
tively. From the plot of Ao/(A  Ao) to 1/[DNA], the ratio of
the intercept to the slope gave the values of binding constant,
Kb, Fig. 2, Table 1.
The order of magnitude of binding constant at both the pH
values (104 M1) for both investigated compounds revealed
their stronger binding with DNA via intercalation. Kb values
calculated for both compounds–DNA complexes at both the
pH values were found comparatively greater than that of atypical intercalator lumazine–DNA complex whose value was
reported as 1.74 · 104 M1 in phosphate buffer of pH (7.2)
(Ibrahim et al., 2002). Similarly the binding values of both
Table 1 Binding constants and free energy values for the compounds–DNA complexes from UV-spectrophotometric data at pH 4.7
and 7.4 and at body temperature (37 C).
Complex code pH 4.7 pH 7.4
Binding constant Kb/M
1 Free energy (DG) kJ mol1 Binding constant Kb/M1 Free energy (DG) kJ mol1
LH–DNA 3.83 · 104 27.20 2.97 · 104 26.54
Ph3SnL–DNA 8.65 · 104 29.30 3.04 · 104 26.60
Table 3 Diffusion coefﬁcients of LH and Ph3SnL before and after the addition of DNA at pH 4.7 and 7.4 and at body temperature
(37 C).
Compound Do (cm
2 s1) at pH 4.7 Do (cm
2 s1) at pH 4.7
Before the addition of DNA After the addition of DNA Before the addition of DNA After the addition of DNA
LH 9.98 · 1010 6.69 · 1012 9.84 · 10-10 7.43 · 1012
Ph3SnL 1.30 · 1010 2.21 · 1011 2.73 · 10-10 3.34 · 1011
Table 2 Binding constants and free energy values for the compounds–DNA complexes from ﬂuorescence spectroscopic data at pH 4.7
and 7.4 and at body temperature (37 C).
Complex code pH 4.7 pH 7.4
Binding
constant Kb/M
1
Binding site
size (n)
Free Energy
(DG) kJ mol1
Binding
constant Kb/M
1
Binding site
size (n)
Free Energy
(DG) kJ mol1
LH–DNA 2.51 · 104 1.04 25.106 2.40 · 104 1.03 24.695
Ph3SnL–DNA 5.49 · 104 1.12 27.179 2.77 · 104 1.05 26.645
456 N. Arshad et al.compounds–DNA complexes were found greater than that of
another important intercalator proﬂavine (K= 2.32 ±
0.41 · 104 M1) and a clinically used chemotherapeutic agent
epirubicin (K= 3.4 · 104 M1) (Aslanoglu, 2006; Charak
et al., 2011), specially at stomach pH (4.7) and are also in good
agreement with that reported for anthracycline molecules for
their binding with DNA (K  104–105 M1) (Li et al., 2005).
This comparison showed stronger interactions of both the
compounds with DNA and their importance as prior compet-
itor in the queue of potential anticancer drug candidates. Bind-
ing constants at stomach pH (4.7) for both compounds were
evaluated comparatively greater than that at pH (7.4), Table 1.
In addition, greater Kb values at stomach pH (4.7) are pre-
sumed to the formation of comparatively more stable complex
formation of the compounds with DNA at this pH than that at
blood pH (7.4), (Arshad et al., 2012a,b), Table 1. The greater
binding constants of investigated compounds at both the pH
values may further be attributed to their structural planarity
due to phenyl groups in the investigated compounds (Arshad
et al., 2013; Arshad et al., 2012a). Binding order of both the
compounds at pH 4.7 and pH 7.4 is given below.
KbðPh3SnLÞ > KbðLHÞ
ðAt both stomach 4:7 and blood 7:4pHÞ
and
Kbðstomach;4:7 pHÞ > Kbðblood;7:4 pHÞ
Gibbs free energy changes DG of compounds–DNA complexes
were calculated using Eq. (3). The values were found negative
which indicated the involvement of spontaneous processesduring compounds–DNA complex formation (Ibrahim et al.,
2002), Table 3.
DG ¼ RT lnKbðkJ mol1Þ ð3Þ
The sequence in DG values of the compounds–DNA complexes
was found same as for binding constant values at both
stomach and blood pH i.e. DG (Ph3SnL) > DG (LH), at both
stomach 4.7 and blood 7.4 pH and DG (stomach; 4.7
pH) > DG (blood; 7.4 pH).
3.3. DNA binding study by ﬂuorescence-spectroscopy
Compound–DNA binding interaction could be probed
through ﬂuorescence-spectroscopy by direct addition of differ-
ent concentrations of DNA, bearing in mind that the investi-
gated compound is ﬂuorescence active (Arjmand et al.,
2012). The intrinsic ﬂuorescence emission spectra of LH and
Ph3SnL were recorded separately and both compounds were
found luminescent, Fig. S4 (in supplementary information).
Then spectral responses of both compounds were recorded
separately by gradually adding concentrations of DNA from
10 to 60 lM. The effect on the ﬂuorescence emission spectra
of compounds LH and Ph3SnL is given in Fig. 3. Upon addi-
tion of DNA, enhancement in the emission intensities of LH
and Ph3SnL was recorded to be greater than those in the
absence of DNA as 3.26 and 4.25 times respectively at pH
4.7 and 3.12 and 4.05 times respectively at pH 7.4. This
increase in the emission intensity after the addition of DNA
is indicative of compound–DNA complex formation via
intercalative mode of interaction (Arjmand et al., 2012).
Figure 3 Fluorescence emission spectra for (A) LH and (B) Ph3SnL (2.8 · 105 M) without and in the presence of 10–60 lMDNA at pH
4.7 (left hand side) and pH 7.4 (right hand side) and at 37 C. The arrow direction indicates increasing concentrations of DNA.
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interacting compound due to its hydrophobic intercalation
into the stacked bases of DNA is indicative of the rise in its
quantum efﬁciency and that the compound is protected from
the water molecules by the hydrophobic microenvironment
of nitrogenous bases inside the DNA-helix (Ruiz et al.,
2011). As a result mobility of the compound is restricted at
the binding sites which then reduce the vibrational mode of
relaxation after excitation and a visible increase is observed
in ﬂuorescence emission intensity during compound–DNA
complex formation (Feng et al., 1998).
Since ﬂuorescence emission intensity is varied after addition
of DNA, the binding constant ‘‘Kb’’ of pro-drug–DNA com-
plex can be determined from the variation in ﬂuorescence emis-
sion intensity spectra. Binding constant ‘‘Kb’’ and binding
stoichiometry have been evaluated spectrophotometrically by
using the following equation (Shahabadi and Fatahi, 2010).
log
F Fo
F
¼ logKb þ n log½DNA ð4Þ
where, Fo and F are the ﬂuorescence intensities of the ﬂuoro-
phore in the absence and in the presence of different concen-
trations of DNA, respectively. Kb and n are the binding
constant and binding site size (binding stoichiometry) respec-
tively which were determined by plotting log [(F  Fo)/F] vs.
log [DNA], Fig. 4 (only shown for Ph3SnL–DNA at both
pH values and at 37 C, for LH–DNA provided as Fig. S5
in supplementary information).Binding constant, binding site size (n) values of both the
compounds were calculated and given in Table 2. The data
obtained for Kb from ﬂuorescence spectroscopy are compatible
with those obtained from UV-results and further veriﬁed
stronger binding of compounds with DNA via intercalation
at both pH values and the formation of most stable complexes
of Ph3SnL and LH with DNA at stomach pH. The binding site
sizes (n) evaluated for both compound–DNA complexes were
found to be slightly greater than 1 (n> 1) at both pH values,
Table 2. It showed that both compounds might have binding
with DNA double helix through hydrogen bonding along with
the intercalative binding of planar phenyl groups present in
investigated compounds (Arshad et al., 2013; Arshad et al.,
2012a; Xu et al., 2005). The negative values of DG calculated
through ﬂuorescence results further supported the UV-results
of free energy changes and indicated the spontaneous binding
of both the compounds with DNA, Table 2. The orders of Kb
and DG values of the compounds–DNA complexes at both pH
values were found similar as obtained by UV-spectroscopy.
3.4. DNA binding study by cyclic voltammetry
Cyclic voltammetry is considered one of the well-liked tech-
niques for the study of DNA binding with small molecule
depending on the fact that compounds bound to DNA are
redox active (Hajin et al., 2012). Electrochemical behavior of
compounds LH and Ph3SnL was investigated using the cyclic
voltammetric technique in ethanol–water mixture (7:3) at a
Figure 4 Plots of log [(F  Fo)/F] vs. log [DNA] for the calculation of Ph3SnL–DNA binding constant and binding site size at pH 4.7 (A)
and 7.4 (B) and at 37 C.
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LH and Ph3SnL showed irreversible reduction processes and
a single peak was observed at reduction potential (EPc) of
0.896 V, 0.915 V, respectively at pH 4.7 and 0.878 V,
0.865 V, respectively at pH 7.4 (Fig. S6 in supplementary
information). Peak broadening was observed for all the com-
pounds at both pH values, which may be attributed to one step
two electron reduction process (Shujha et al., 2010).
Voltammetric responses were recorded after the addition of
1–60 lM DNA on optimized concentration (2.8 · 105 M) of
LH and Ph3SnL at both pH values. A decrease in peak height
{(LH; 48.8% (pH 4.7), 47.2% (pH 7.4) and Ph3SnL; 64.4%
(pH 4.7), 62.3% (pH 7.4)} was observed along with a negative
shift in the reduction peak potential {(LH; 18 mV (pH 4.7),
29 mV (pH 7.4) and Ph3SnL; 53 mV (pH 4.7), 46 mV (pHFigure 5 Cyclic voltammetric responses for (A) LH and (B) Ph3SnL
pH 4.7 (left hand side) and pH 7.4 (right hand side) and at 37 C. Th7.4)}, Fig. 5. Such changes in the cyclic voltammogram of a
redox active compound after the addition of DNA have been
reported for compound–DNA complex formation via interca-
lation (Arshad et al., 2013; Arshad et al., 2012b; Niranjana
et al., 2008).
Randles-Sevcik equation is used to determine the diffusion
coefﬁcient values of LH and Ph3SnL without and in the pres-
ence of DNA (Randles, 1948; Sevcik, 1948).
Ip ¼ 2:995nðanaÞ1=2ACoD1=2o m1=2 ð5Þ
where, Ip is peak current in amperes (A), n is charge transfer
number, na is number of electrons transferred up to and
including the rate determining step, a is transfer coefﬁcient
(generally, 0.3 < a< 0.7), A is surface area of the electrode
(cm2), Co
* is bulk concentration of the electro active species(2.8 · 105 M) without and in the presence of 10–60 lM DNA at
e arrow direction indicates increasing concentrations of DNA.
Figure 6 Cyclic voltammogram for Ph3SnL at different scan
rates (Vs1) in ethanol-water mixture (7:3) in the absence (top) and
in the presence (bottom) of ds-DNA at pH 4.7. The arrows
direction indicates increasing scan rates (Vs1) as; 0.02, 0.05,
0.075, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.25, 0.275, 0.30, 0.325,
and 0.350. Inset: Plots of Ip vs. m
1/2 for Ph3SnL (2.8 · 105 M) at
pH 4.7 (acetate buffer) in the absence (top) and in the presence of
60 lM DNA (bottom) at various scan rates (Vs1).
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coefﬁcient (cm2 s1).
Ip values were plotted ms. m
1/2 for both compounds without
and in the presence of DNA which showed linear dependencyFigure 7 Plots of Ip
2 vs. Ipo
2  Ip2/[DNA] for calculation of binding co
37 C.of peak currents on the square root of scan rates, Fig. 6 (only
shown Ph3SnL at pH 4.7 (others provided as Fig. S7 in supple-
mentary information)). The linearity of plots veriﬁed that main
mass transport of these electro active species and their DNA
bound complexes is diffusion controlled (Arshad et al.,
2012b). A negative shift in the peak potential along with an
increase in peak current by increasing the scan rate may fur-
ther be attributed to irreversible nature of redox process
(Niranjana et al., 2008) occurring in compounds with and
without the addition of DNA, Fig. 6. Number of electrons
(n) were calculated using equation; Ep Ep/2 = 47.7 mV/an.
Assuming the value of a to be 0.5, the values of n for both
compounds were evaluated approximately equal to 2 which
suggests that redox reaction of compounds is an irreversible
process and two electrons are involved in the one step reduc-
tion process (Wang et al., 2011).
The diffusion coefﬁcients of compounds LH and Ph3SnL
before and after the addition of DNA were calculated and
given in Table 3. The lower diffusion coefﬁcient (Do) values
of DNA bound organotin carboxylates are responsible for
the decay of peak current in cyclic voltammograms, Fig. 6.
The binding constants, Kb, for both the compounds for
their complexation with DNA were calculated according to
the following equation which is based on variation in peak cur-
rents as in present studies decrease in peak current of com-
pounds by the addition of different concentrations of DNA
was observed, (Niu et al., 1994).
I2p ¼
1
Kb½DNA I
2
po  I2p
 
þ I2po  ½DNA ð6Þ
where Kb is the binding constant, Ip and Ipo are the peak cur-
rents with and without DNA. A plot of Ip
2 vs. (Ipo
2  Ip2)/
[DNA] gave a straight line with a slope equal to the reciprocal
of binding constant, Kb, Fig. 7 (only shown for Ph3SnL–DNA
at both pH values and at 37 C, for LH–DNA provided as
Fig. S8 in supplementary information).
The binding constant values were calculated and given in
Table 4. Both the compounds showed stronger binding with
DNA at stomach pH as evident from comparatively greater
Kb values at this pH, Table 4. Kb values obtained through
voltammetric parameters were also found in good agreement
with those obtained from UV- and ﬂuorescence results hence
conﬁrming the compatibility of binding constant results from
all the three complementary techniques. Gibbs free energy
changes evaluated through Kb data using CV parameters
were found as negative values as obtained through UV- and
ﬂuorescence results and further inveterate the involvement ofnstant of Ph3SnL–DNA adducts at pH 4.7 (A) and 7.4 (B) and at
Table 5 Antitumor activity of the compounds as evaluated by
potato disc antitumor assay and their IC50 values.
Sample code IC50 (lg ml
1)
LH 149.77
Ph3SnL 14.02
Vincristine 0.003
DMSO –
Table 4 Binding constants and free energy values for the compounds–DNA complexes from voltammetric data at pH 4.7 and 7.4 and
at body temperature (37 C).
Complex code pH 4.7 pH 7.4
Binding
constant Kb/
M1
Binding site
size (n)
Free Energy
(DG) kJmol-1
Binding
constant Kb/
M1
Binding site
size (n)
Free Energy
(DG) kJmol-1
LH–DNA 5.35 · 104 1.34 28.1 2.6 · 104 1.05 26.2
Ph3SnL–DNA 8.85 · 104 2.84 29.4 3.58 · 104 2.07 36.9
460 N. Arshad et al.spontaneous process in compound–DNA binding, Table 5.
The orders in the value of binding constant as well as free
energy change were found to be identical as obtained by both
spectroscopic techniques at both pH values.
Kinetics and thermodynamic studies through all the
complementary techniques revealed that both LH and Ph3SnL
compounds bind comparatively more strongly and more
spontaneously with ds.DNA at stomach pH (4.7) than that
at blood pH (7.4). Also, among both the compounds tin com-
plex (Ph3SnL) showed comparatively greater binding than that
of its ligand (LH) at both the pH values.
Binding site sizes (n) were evaluated through cyclic voltam-
metry by using the following equation (Carter et al., 1989).
Cb=Cf ¼ K½free base pairs=s ð7Þ
where, s is the binding site size in terms of base pairs (bp).
Measuring the concentration of DNA in terms of compound
concentration, the concentration of the base pairs can be
expressed as [DNA]/2. So Eq. (7) can be written as:
Cb=Cf ¼ K½DNA=2 s ð8Þ
Cf and Cb denote the concentration of the free and DNA
bound species respectively. The Cb/Cf ratio was determined
by the equation given below (Aslanoglu et al., 2000).Figure 8 Plots of I  IDNA/IDNA vs. [DNA] for determination of bin
and at 37 C.Cb=Cf ¼ I IDNA=IDNA ð9Þ
where I and IDNA represent the peak currents of the compound
in the absence and in the presence of DNA, respectively. Putt-
ing the value of Kb as calculated according to Eq. (7), the bind-
ing site size was obtained from the plot of I  IDNA/IDNA vs.
[DNA], Fig. 8 (only shown for Ph3SnL –DNA at both pH val-
ues and at 37 C, others provided as Fig. S9 in supplementary
information).
The binding site size (n) was calculated and found greater
than 1 (n > 1) for both compound–DNA complexes, Table 4,
the reason being same as discussed in previous section. The
values of n obtained at both pH values are consistent with
those obtained through ﬂuorescence spectroscopy.
3.5. Compound DNA-binding veriﬁcation by viscometric
analysis
Binding mode of interaction as investigated through spectro-
scopic and electrochemical techniques could be veriﬁed by vis-
cosity measurements (Shahabadi et al., 2011). An increase in
the relative viscosity of DNA by gradual addition of various
concentrations of the compound is indicative of intercalation
binding mode (Shahabadi et al., 2011; Liu et al., 1993). This
is further attributed to the lengthening of DNA helix as the
size of base pair pockets is increased to accommodate the com-
pound as observed for a classical intercalator, ethidium bro-
mide (Shahabadi et al., 2011).
Upon addition of various concentrations of investigated
compounds (LH and Ph3SnL) on ﬁxed concentration of
DNA (10 lM) at both stomach (4.7) and blood (7.4) pH, a
gradual rise in the curves was observed when values of the rel-
ative speciﬁc viscosities for the compounds i.e., (g/go)
1/3 were
plotted vs. [compound]/[DNA], Fig. 9. Where, go and g areding site size of Ph3SnL–DNA adducts at pH 4.7 (A) and 7.4 (B)
Figure 9 Plots of relative speciﬁc viscosity vs. [compound]/[DNA] for LH and Ph3SnL at pH 4.7 (A) and 7.4 (B) and at 37 C.
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in the presence of the investigated compounds respectively.
This behavior could be ascribed as enhancement in the length
of DNA helix via intercalation of the compounds within DNA
base pairs (Shahabadi et al., 2011; Liu et al., 1993) and further
veriﬁed our spectroscopic and voltammetric ﬁndings.
3.6. Free radical scavenging ﬁndings
DPPH assay measures changes in DPPH color from purple to
yellow followed by a decrease in absorption at 517 nm after
reacting with the test compounds which is indicative of
scavenging potential of the antioxidant compound. Both com-
pounds showed no signiﬁcant DPPH free radical scavenging
activity as color changes and decrease in absorption at
517 nm were not observed for various concentrations used.
All the compounds have IC50 value >200 lg ml
1.
3.7. Potato disc antitumor ﬁndings
The inhibition of A. tumefaciens-induced tumors (or Crown
Gall) in potato disc tissue is an assay based on antimitotic
activity, and can detect a broad range of known and novel
antitumor effects (McLaughlin and Rogers, 1998). This assay
is based on the hypothesis that antitumor agents might inhibit
the initiation and growth of tumors in both plant and animal
systems, because certain tumorogenic mechanisms are similar
in plants and animals (Coker et al., 2003). The results obtained
from potato disc antitumor assay and from other most com-
monly used antitumor screening assays had shown good corre-
lation as tumor induction mechanisms are reported to be
similar in both plants and animals (Rehman et al., 2001). Both
compounds (LH and Ph3SnL) were investigated against A.
tumefaciens (At 10) for their antitumor potentials. Effect of
increasing concentrations of both compounds on tumor for-
mation ability of bacterium was examined and IC50 values
were calculated. Vincristine (positive control) showed 100%
tumor inhibition at all the concentrations tested whereas
DMSO (negative control) has no interference with the activity
of bacterium to induce tumors. Furthermore, the inhibition
was observed in a dose dependent manner with the highest
inhibition at 200 lg ml1 concentration. Antitumor activity
can also be determined by 50% inhibitory concentration (cal-
culated by inhibition curves of four concentrations tested for
each compound). Among both compounds, Ph3SnL exhibitedthe best tumor inhibitory activity with lowest IC50 value of
14.02 lg ml1, Table 5.
4. Conclusion
(Z)-4-(4-cyanophenylamino)-4-oxobut-2-enoic acid (LH) and
its new triphenyltin(IV) derivative (Ph3SnL) were synthesized,
characterized and investigated for in-vitro binding with DNA
as well as bioactivities using spectroscopy (UV–Visible, ﬂuores-
cence), cyclic voltammetry and bioassays. Spectral and voltam-
metric responses as well as kinetic and thermodynamic data
interpretation (i.e. binding constants, Kb, binding site size, n,
and free energy change, DG) revealed spontaneous binding of
both the compounds with DNA via intercalation. Experimental
evidences from both spectroscopic techniques and cyclic
voltammetry were comparable and among two compounds
Ph3SnL showed comparatively stronger binding with DNA at
both the pH {stomach (4.7) and blood (7.4)} and at 37 C. In
general the binding was evaluated greater at stomach pH. Inter-
calative binding mode was further veriﬁed by viscosity measure-
ments which showed an increasing trend in the relative viscosity
of DNA when various concentrations of the compound were
added gradually. Antioxidant and antitumor activities through
biological assays showed no signiﬁcant antioxidant activity of
both the compounds, while the lowest IC50 value was evaluated
for Ph3SnLwhich showed its best tumor inhibitory activity than
that of LH. Results obtained for antitumor potential and DNA
binding studies (Kb values) are correlated with each other and
further authenticate the signiﬁcance of our present investiga-
tions. These promising results of quantitative ﬁndings through
both chemical and biological analysis and further investigations
in this direction will hopefully lead to ﬁnd out more effective
metal based anticancer drug candidates.
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